ID   T-289/DPP3
AC   CVCL_GZ32
SY   289 DPP3
DR   Wikidata; Q54583795
RX   PubMed=8752169;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8760 ! T-289
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 5
//
RX   PubMed=8752169;
RA   McClay, Edward Francis
RA   Jones, Jeffrey A.
RA   Winski, Paul J.
RA   Albright, Kathleen D.
RA   Christen, Randolph D.
RA   Howell, Stephen B.
RT   "Determinants of tamoxifen sensitivity control the nature of the
RT   synergistic interaction between tamoxifen and cisplatin.";
RL   Cancer Res. 56:3993-3997(1996).
//